Cita APA

L, I., C, V., S, C., & F, D. Z. (2004). Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: The key role of early, low-dose flutamide.

Citación estilo Chicago

L, Ibáñez, Valls C, Cabré S, y De Zegher F. Flutamide-metformin Plus Ethinylestradiol-drospirenone for Lipolysis and Antiatherogenesis in Young Women With Ovarian Hyperandrogenism: The Key Role of Early, Low-dose Flutamide. 2004.

Cita MLA

L, Ibáñez, Valls C, Cabré S, y De Zegher F. Flutamide-metformin Plus Ethinylestradiol-drospirenone for Lipolysis and Antiatherogenesis in Young Women With Ovarian Hyperandrogenism: The Key Role of Early, Low-dose Flutamide. 2004.